209 related articles for article (PubMed ID: 22474295)
1. Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis.
Toro EJ; Zuo J; Ostrov DA; Catalfamo D; Bradaschia-Correa V; Arana-Chavez V; Caridad AR; Neubert JK; Wronski TJ; Wallet SM; Holliday LS
J Biol Chem; 2012 May; 287(21):17894-17904. PubMed ID: 22474295
[TBL] [Abstract][Full Text] [Related]
2. Bis-enoxacin inhibits bone resorption and orthodontic tooth movement.
Toro EJ; Zuo J; Gutierrez A; La Rosa RL; Gawron AJ; Bradaschia-Correa V; Arana-Chavez V; Dolce C; Rivera MF; Kesavalu L; Bhattacharyya I; Neubert JK; Holliday LS
J Dent Res; 2013 Oct; 92(10):925-31. PubMed ID: 23958763
[TBL] [Abstract][Full Text] [Related]
3. Rational identification of enoxacin as a novel V-ATPase-directed osteoclast inhibitor.
Toro EJ; Ostrov DA; Wronski TJ; Holliday LS
Curr Protein Pept Sci; 2012 Mar; 13(2):180-91. PubMed ID: 22044158
[TBL] [Abstract][Full Text] [Related]
4. Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening.
Ostrov DA; Magis AT; Wronski TJ; Chan EK; Toro EJ; Donatelli RE; Sajek K; Haroun IN; Nagib MI; Piedrahita A; Harris A; Holliday LS
J Med Chem; 2009 Aug; 52(16):5144-51. PubMed ID: 19630402
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of osteoclast bone resorption by disrupting vacuolar H+-ATPase a3-B2 subunit interaction.
Kartner N; Yao Y; Li K; Crasto GJ; Datti A; Manolson MF
J Biol Chem; 2010 Nov; 285(48):37476-90. PubMed ID: 20837476
[TBL] [Abstract][Full Text] [Related]
6. Interaction between vacuolar H(+)-ATPase and microfilaments during osteoclast activation.
Lee BS; Gluck SL; Holliday LS
J Biol Chem; 1999 Oct; 274(41):29164-71. PubMed ID: 10506172
[TBL] [Abstract][Full Text] [Related]
7. Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.
Crasto GJ; Kartner N; Yao Y; Li K; Bullock L; Datti A; Manolson MF
J Cell Biochem; 2013 Apr; 114(4):929-41. PubMed ID: 23129004
[TBL] [Abstract][Full Text] [Related]
8. Actin binding activity of subunit B of vacuolar H+-ATPase is involved in its targeting to ruffled membranes of osteoclasts.
Zuo J; Jiang J; Chen SH; Vergara S; Gong Y; Xue J; Huang H; Kaku M; Holliday LS
J Bone Miner Res; 2006 May; 21(5):714-21. PubMed ID: 16734386
[TBL] [Abstract][Full Text] [Related]
9. Vacuolar H+-ATPase binding to microfilaments: regulation in response to phosphatidylinositol 3-kinase activity and detailed characterization of the actin-binding site in subunit B.
Chen SH; Bubb MR; Yarmola EG; Zuo J; Jiang J; Lee BS; Lu M; Gluck SL; Hurst IR; Holliday LS
J Biol Chem; 2004 Feb; 279(9):7988-98. PubMed ID: 14662773
[TBL] [Abstract][Full Text] [Related]
10. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.
Feng S; Deng L; Chen W; Shao J; Xu G; Li YP
Biochem J; 2009 Jan; 417(1):195-203. PubMed ID: 18657050
[TBL] [Abstract][Full Text] [Related]
11. From lysosomes to the plasma membrane: localization of vacuolar-type H+ -ATPase with the a3 isoform during osteoclast differentiation.
Toyomura T; Murata Y; Yamamoto A; Oka T; Sun-Wada GH; Wada Y; Futai M
J Biol Chem; 2003 Jun; 278(24):22023-30. PubMed ID: 12672822
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphene attenuates multinucleation of pre-osteoclasts by suppressing expression of cell-cell fusion-associated genes DC-STAMP, OC-STAMP, and Atp6v0d2.
Takagi T; Inoue H; Takahashi N; Katsumata-Tsuboi R; Uehara M
Biosci Biotechnol Biochem; 2017 Jun; 81(6):1220-1223. PubMed ID: 28136694
[TBL] [Abstract][Full Text] [Related]
13. Interactions between vacuolar H+-ATPases and microfilaments in osteoclasts.
Holliday LS; Bubb MR; Jiang J; Hurst IR; Zuo J
J Bioenerg Biomembr; 2005 Dec; 37(6):419-23. PubMed ID: 16691476
[TBL] [Abstract][Full Text] [Related]
14. The R740S mutation in the V-ATPase a3 subunit results in osteoclast apoptosis and defective early-stage autophagy.
Ochotny N; Voronov I; Owen C; Aubin JE; Manolson MF
J Cell Biochem; 2013 Dec; 114(12):2823-33. PubMed ID: 23908015
[TBL] [Abstract][Full Text] [Related]
15. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis.
Xu J; Cheng T; Feng HT; Pavlos NJ; Zheng MH
Histol Histopathol; 2007 Apr; 22(4):443-54. PubMed ID: 17290355
[TBL] [Abstract][Full Text] [Related]
17. Specialized Roles for Actin in Osteoclasts: Unanswered Questions and Therapeutic Opportunities.
Han G; Zuo J; Holliday LS
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30634501
[TBL] [Abstract][Full Text] [Related]
18. A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform.
Nyman JK; Väänänen HK
Calcif Tissue Int; 2010 Sep; 87(3):273-83. PubMed ID: 20596699
[TBL] [Abstract][Full Text] [Related]
19. Blocking of sodium and potassium ion-dependent adenosine triphosphatase-α1 with ouabain and vanadate suppresses cell-cell fusion during RANKL-mediated osteoclastogenesis.
Makihira S; Nikawa H; Kajiya M; Kawai T; Mine Y; Kosaka E; Silva MJ; Tobiume K; Terada Y
Eur J Pharmacol; 2011 Nov; 670(2-3):409-18. PubMed ID: 21945676
[TBL] [Abstract][Full Text] [Related]
20. Vacuolar H+-ATPase activity and expression in mouse bone marrow cultures.
Lee BS; Holliday LS; Krits I; Gluck SL
J Bone Miner Res; 1999 Dec; 14(12):2127-36. PubMed ID: 10620072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
